[The protection of myocardial ischemia--reperfusion injury].
Miura
Mamoru
M
Second Department of Internal Medicine, Akita University School of Medicine.
Fujiwara
Yoshimasa
Y
D000241:Adenosine / Q000008:administration & dosage / Q000502:physiology; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D015815:Cell Adhesion Molecules / Q000502:physiology; D019332:Endothelin-1 / Q000502:physiology; D005609:Free Radicals / Q000378:metabolism; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D015428:Myocardial Reperfusion Injury / Q000209:etiology* / Q000517:prevention & control*; D009569:Nitric Oxide / Q000502:physiology; D020030:Nitric Oxide Donors / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D015815:Cell Adhesion Molecules; D019332:Endothelin-1; D005609:Free Radicals; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D020030:Nitric Oxide Donors; D009569:Nitric Oxide; D000241:Adenosine; D002118:Calcium